Matthew Thomas

1PUBLICATIONS
2CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 16, 2024
First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments.

Aung Naing, Danny Khalil, Oliver Rosen

Pageof 1

Frequent Collaborators

1 joint publications

Aung Naing

1 joint publications

Oliver Rosen